TBIO: מקדם מחיר להכנסות Codex DNA

Telesis Bio, Inc. (TBIO) generates revenue through the sale of automated gene synthesizers and related materials. The median P/S from GURU.Markets is used to analyze the trend, where the metric value is 0.30. While the environmental efficiency of the systems reduces the carbon footprint of laboratories, operating losses and slow technology adoption create significant risks for the company's capitalization within the synthetic biology sector.

The efficiency of DNA synthesis system logistics and reagent supplies directly impacts the price-to-sales valuation of Telesis Bio, Inc. (TBIO). This multiple compares the company's total market capitalization to its annual revenue, allowing investors to identify asset overheating when quotes deviate from historical norms and determine the equilibrium point to assess the stability of invested capital.